Back
#1
32.0%
Top 4%
6.6%
Top 17%
6.1%
Top 1%
6.1%
Top 27%
6.1%
Top 75%
6.1%
Top 2%
5.2%
Top 0.7%
2.9%
Top 4%
2.0%
Top 11%
2.0%
Top 3%
1.6%
Top 2%
1.4%
Top 2%
1.4%
Top 24%
1.2%
Top 12%
1.2%
Top 17%
1.0%
Top 0.3%
1.0%
Top 33%
0.7%
Top 16%
0.7%
Top 2%
0.7%
Top 6%
0.7%
Top 33%
0.7%
Effectiveness of BNT162b2 COVID-19 Vaccination in Children Aged 5-17 Years in the United States
2023-09-08
public and global health
Title + abstract only
View on medRxiv
Show abstract
ImportanceCOVID-19 vaccines are authorized for use in children in the United States; real-world assessment of vaccine effectiveness in children is needed. ObjectiveTo estimate the effectiveness of receiving a complete primary series of monovalent BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine in US children. DesignA cohort study of children aged 5-17 years vaccinated with BNT162b2 matched with unvaccinated children. SettingParticipants identified in Optum and CVS Health insurance administrative ...
Predicted journal destinations
1
Vaccine
140 training papers
2
Clinical Infectious Diseases
219 training papers
3
Nature Communications
483 training papers
4
Vaccines
131 training papers
5
BMJ Open
553 training papers
6
PLOS ONE
1737 training papers
7
JAMA Network Open
125 training papers
8
BMJ
49 training papers
9
PLOS Medicine
95 training papers
10
BMC Medicine
155 training papers
11
The Lancet Infectious Diseases
57 training papers
12
New England Journal of Medicine
49 training papers
13
eClinicalMedicine
55 training papers
14
BMC Public Health
148 training papers
15
The Journal of Infectious Diseases
137 training papers
16
BMJ Global Health
95 training papers
17
The Lancet Regional Health - Americas
20 training papers
18
Frontiers in Public Health
135 training papers
19
Nature Medicine
88 training papers
20
The Journal of Pediatrics
15 training papers
21
Cell Reports Medicine
49 training papers
22
PLOS Global Public Health
287 training papers